Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model

Rozenbaum, Mark H.; Mangen, Marie-Josee J.; Giaquinto, Carlo; Wilschut, Jan C.; Hak, Eelko; Postma, Maarten J.
January 2011
BMC Public Health;2011 Supplement 4, Vol. 11 Issue Suppl 4, p462
Academic Journal
Background: Each year rotavirus gastroenteritis results in thousands of paediatric hospitalisations and primary care visits in the Netherlands. While two vaccines against rotavirus are registered, routine immunisation of infants has not yet been implemented. Existing cost-effectiveness studies showed inconsistent results for these vaccines because of lack of consensus on the impact. We aimed to investigate which factors had a major impact on costeffectiveness and were primarily responsible for the large differences in previously estimated cost-effectiveness ratios. Methods: Based on updated data on health outcomes and cost estimates, we re-assessed the cost-effectiveness of routine paediatric rotavirus vaccination within the National Immunization Program for the Netherlands. Two consensus meetings were organised with national and international experts in the field to achieve consensus and resolve potential controversies. Results: It was estimated that rotavirus vaccination in the Netherlands could avert 34,214 cases of rotavirus gastroenteritis in children aged less than 5 years. Notably, 2,779 hospitalisations were averted of which 315 were extensions of existing hospital stays due to nosocomial rotavirus infection. With a threshold varying from 20K€ - 50K€ per QALY and according to the base-case scenario, the full vaccination costs per child leading to costeffectiveness was €57.76 -€77.71. Results were sensitive to the inclusion of potential vaccine induced herd protection, QALY losses and number of deaths associated with rotavirus gastroenteritis. Conclusions: Our economic analysis indicates that inclusion of rotavirus vaccination in the Dutch National Immunization Program might be cost-effective depending on the cost of the vaccine and the impact of rotavirus gastroenteritis on children's quality of life.


Related Articles

  • All-Cause Gastroenteritis and Rotavirus-Coded Hospitalizations Among US Children, 2000–2009. Desai, Rishi; Curns, Aaron T.; Steiner, Claudia A.; Tate, Jacqueline E.; Patel, Manish M.; Parashar, Umesh D. // Clinical Infectious Diseases;8/15/2012, Vol. 55 Issue 4, pe28 

    Since the approval of rotavirus vaccine in 2006 for routine use in US children, there has been a marked reduction in the number of and direct medical charges for all-cause gastroenteritis hospitalizations and rotavirus-coded hospitalizations.Background. Rotavirus vaccine was recommended for US...

  • Epidemiological changes in rotavirus gastroenteritis in children under 5 years of age after the introduction of rotavirus vaccines in Korea. Choi, Ui; Lee, Soo; Ma, Sang; Jang, Young; Kim, Jae; Kim, Hwang; Kim, Jong; Kim, Dong; Kim, Yong; Kang, Jin // European Journal of Pediatrics;Jul2013, Vol. 172 Issue 7, p947 

    Rotavirus gastroenteritis is the leading cause of severe acute gastroenteritis in children worldwide and is associated with high hospitalization and mortality rates in children younger than 5 years of age. Vaccination is necessary to prevent rotavirus infection. Two live attenuated and orally...

  • Rotavirus Vaccination Schedule.  // Immunization Newsletter;Oct2012, Vol. 34 Issue 5, p3 

    The article offers information on rotavirus vaccination schedule in Latin America and the Caribbean.

  • Ghana vaccine expansion.  // Bulletin of the World Health Organization;Jun2012, Vol. 90 Issue 6, p405 

    The article reports that in 2012 the country of Ghana has introduced pneumococcal and rotavirus vaccines to help prevent childhood pneumonia and diarrhea.

  • Intussusception rate not increased by rotavirus vaccine in US.  // Reactions Weekly;2/4/2012, Issue 1387, p3 

    The article reports that reintroduction of the rotavirus vaccine in the U.S. since 2006 has not resulted in any increase in the rate of hospital discharges for intussusception.

  • Call for more vaccines on funded list. Castaneda, Reynald // New Zealand Doctor;5/8/2013, p14 

    The article discusses the hope by academics that varicella and rotavirus vaccines will be included in the priority list for vaccines on the immunisation schedule in New Zealand.

  • Rotavirus Vaccination Programme is not Only about Costs. Vesikari, Timo // Journal of Pediatric Infection / Cocuk Enfeksiyon Dergisi;Mar2013, Vol. 7 Issue 1, p1 

    The author reflects on a national rotavirus vaccination program in Turkey and on the article "Cost Effectiveness of Both (Monovalent and Pentavalent) Rotavirus Vaccines" by M. Hacımustafaoğlu et al. He suggests that rotavirus can be prevented by a simple oral vaccination which is safe and...

  • The Dominican Republic Introduces Rotavirus Vaccine into National Immunization Schedule.  // Immunization Newsletter;Aug2012, Vol. 34 Issue 4, p4 

    The article reports on the introduction of rotavirus vaccine by the Dominican Republic on July 4, 2012 into its national immunization schedule for preventing diarrhea in children and avoid mortality.

  • Free rotavirus vaccine will be a one-week rush for some. Castaneda, Reynald // New Zealand Doctor;4/23/2014, p5 

    The article reports on the changes in the immunization schedule wherein the rotavirus vaccine RotaTeq (MSD) will be made available free for infants under 15 weeks in New Zealand beginning July 1, 2014.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics